NCT02327013View on ClinicalTrials.gov

Investigating the Effect of Vortioxetine in Adult ADHD Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

vortioxetine 10 mg tablet

Oral tablets, once daily

DRUG

vortioxetine 20 mg tablet

Oral tablets, once daily

OTHER

Placebo tablet

Oral tablets, once daily

Trial Locations (15)

Unknown

US015, Beverly Hills

US002, Garden Grove

US004, National City

US013, Bradenton

US006, Gainesville

US010, Alpharetta

US014, Libertyville

US011, Baltimore

US009, Boston

US016, Las Vegas

US005, New York

US008, New York

US001, Austin

US007, Herndon

US003, Bellevue

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT02327013 - Investigating the Effect of Vortioxetine in Adult ADHD Patients | Biotech Hunter | Biotech Hunter